Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 181 AL 195

Morphometric imaging biomarker identifies Alzheimer's disease even among mixed dementia patients

Chirila FV, Xu G, Fontaine D, Kern G, Khan TK, Brandt J, Konishi Y, Nebe-von-Caron G, White CL 3rd, Alkon DL.

Sci Rep. 2022 Nov 1;12(1):17675. doi: 10.1038/s41598-022-21796-y.

[Imaging of neuropathology by PET tracers]

Harada R.

Nihon Yakurigaku Zasshi. 2022;157(6):453-457. doi: 10.1254/fpj.22061.

Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study

Wang HL, Tang R, Ren RJ, Dammer EB, Guo QH, Peng GP, Cui HL, Zhang YM, Wang JT, Xie XY, Huang Q, Li JP, Yan FH, Chen SD, He NY, Wang G.

BMC Med. 2022 Nov 7;20(1):380. doi: 10.1186/s12916-022-02584-x.

Omics-based biomarkers discovery for Alzheimer's disease

Aerqin Q, Wang ZT, Wu KM, He XY, Dong Q, Yu JT.

Cell Mol Life Sci. 2022 Nov 8;79(12):585. doi: 10.1007/s00018-022-04614-6.

Driving assessment in preclinical Alzheimer's disease: progress to date and the path forward

Bayat S, Roe CM.

Alzheimers Res Ther. 2022 Nov 8;14(1):168. doi: 10.1186/s13195-022-01109-1.

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, Stomrud E, Tideman P, Ohlsson T, Jögi J, Johnson K, Sperling R, Dore V, Masters CL, Rowe C, Visser D, van Berckel BNM, van der Flier WM, Baker S, Jagust WJ, Wiste HJ, Petersen RC, Jack CR Jr, Hansson O.

Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.

Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential

Olichney J, Xia J, Church KJ, Moebius HJ.

Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.

Dementia Prevention in Clinical Practice

Niotis K, Akiyoshi K, Carlton C, Isaacson R.

Semin Neurol. 2022 Oct;42(5):525-548. doi: 10.1055/s-0042-1759580. Epub 2022 Nov 28.

β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer's disease

Mohaupt P, Pons ML, Vialaret J, Delaby C, Hirtz C, Lehmann S.

Alzheimers Res Ther. 2022 Nov 30;14(1):179. doi: 10.1186/s13195-022-01125-1.

Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ.

Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.

New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer's Disease

Hao Y, Xie B, Fu X, Xu R, Yang Y.

Biomolecules. 2022 Dec 2;12(12):1802. doi: 10.3390/biom12121802.

The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review

Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ.

Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1.

Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer's disease (ALFASleep project): protocol for an observational study

Fauria K, Minguillon C, Knezevic I, Tort-Colet N, Stankeviciute L, Hernández L, Rădoi A, Deulofeu C, Fuentes-Julián S, Turull I, Fusté D, Sánchez-Benavides G, Arenaza-Urquijo EM, Suárez-Calvet M, Holst SC, Garcés P, Mueggler T, Zetterberg H, Blennow K, Arqueros A, Iranzo Á, Domingo Gispert J, Molinuevo JL, Grau-Rivera O.

BMJ Open. 2022 Dec 30;12(12):e067159. doi: 10.1136/bmjopen-2022-067159.

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease

Shim KH, Kang MJ, Youn YC, An SSA, Kim S.

Alzheimers Res Ther. 2022 Dec 31;14(1):201. doi: 10.1186/s13195-022-01150-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias